PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors
-
Published:2024-09
Issue:9
Volume:9
Page:103653
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Yap T.A.ORCID,
Choudhury A.D.ORCID,
Hamilton E.ORCID,
Rosen L.S.ORCID,
Stratton K.L.,
Gordon M.S.,
Schaer D.,
Liu L.,
Zhang L.ORCID,
Mittapalli R.K.,
Zhong W.,
Soman N.,
Tolcher A.W.